. Author manuscript; available in PMC: 2013 Sep 1.

Published in final edited form as: Psychopharmacology (Berl). 2012 Apr 4;223(1):107–116. doi: 10.1007/s00213-012-2698-9

Table 1.

Overview of treatment design.

Study Days	Week 1	Week 2	Week 3	Week 4	Week 5
Phase	Baseline	Drug Manipulation			Standard
Visits	#1	#2	#3		#4
Varenicline group		V	V	V	V
Placebo group		P	P	P	V

Note: TQD = Target Quit Date; V = varenicline; P = placebo;